Stocks
Atara Biotherapeutics (ATRA) EBITDA margin US GAAP (year values) |
||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | |||
| EBITDA margin, % | ? | -1 628% | -349.6% | -3 103% | -58.7% | 32.0% | -23.9% | |
| Changes by years, y/y, % | +1 278pp | -2 753pp | +3 044pp | +91pp | ||||
Atara Biotherapeutics. EBITDA margin, %
Atara Biotherapeutics. EBITDA margin, changes, pp
Atara Biotherapeutics (ATRA) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA margin, % | ? | 41.6% | 20.5% | -96.4% | -154.4% | -647.3% | -23.9% | |
| Changes by years, y/y, % | +148pp | +78pp | -48pp | -122pp | -689pp | |||
| Changes by quarters, q/q, % | +74pp | -21pp | -117pp | -58pp | -493pp | |||
